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Reduced Inflammatory Threshold Indicates Skin
Barrier Defect in Transglutaminase 3 Knockout Mice
Peter Bognar1, Ilona Nemeth1, Balazs Mayer1, Dora Haluszka1, Norbert Wikonkal1, Eszter Ostorhazi1,
Susan John2, Mats Paulsson2, Neil Smyth3, Maria Pasztoi4, Edit I. Buzas4, Robert Szipocs5, Attila Kolonics5,
Erzsebet Temesvari1 and Sarolta Karpati1
Recently, a transglutaminase 3 knockout (TGM3/KO) mouse was generated that showed impaired hair
development, but no gross defects in the epidermal barrier, although increased fragility of isolated corneocytes
was demonstrated. Here we investigated the functionality of skin barrier in vivo by percutaneous sensitization to
FITC in TGM3/KO (n¼ 64) and C57BL/6 wild-type (WT) mice (n¼ 36). Cutaneous inflammation was evaluated by
mouse ear swelling test (MEST), histology, serum IgE levels, and by flow cytometry from draining lymph
nodes. Inflammation-induced significant MEST difference (Po0.0001) was detected between KO and WT mice
and was supported also by histopathology. A significant increase of CD4þ CD25þ -activated T cells (Po0.01) and
elevated serum IgE levels (Po0.05) in KO mice indicated more the development of FITC sensitization
than an irritative reaction. Propionibacter acnes–induced intracutaneous inflammation showed no difference
(P¼ 0.2254) between the reactivity of WT and KO immune system. As in vivo tracer, FITC penetration
from skin surface followed by two-photon microscopy demonstrated a more invasive percutaneous penetration
in KO mice. The clinically uninvolved skin in TGM3/KO mice showed impaired barrier function and higher
susceptibility to FITC sensitization indicating that TGM3 has a significant contribution to the functionally intact
cutaneous barrier.
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INTRODUCTION
Our knowledge on epidermal differentiation and keratiniza-
tion has significantly grown within the last decade. Recent
studies provide a large amount of information on proteins and
enzymes of the skin barrier; however, their significance in the
clinical setting is only partially understood.
The epidermal barrier has a key role in skin homeostasis
and mostly environmental antigens penetrating this barrier are
able to induce reactions in the skin-associated adoptive and/or
innate immune system and promote irritative or allergic
contact dermatitis.
Transglutaminases (TG) are a group of Ca 2þ -dependent
enzymes, which catalyze formation of covalent isopeptide
bonds and produce stabilizing cross-links between protein
networks. Some of these structures contribute to an effective
barrier in the skin and mucosa. TGs were first described in
1959 (Clarke et al., 1959), but the exact biological function
of a TG enzyme, Factor XIIIa, in the process of blood
coagulation was only discovered in 1968 (Pisano et al.,
1968). So far, eight TGs have been identified (Hitomi et al.,
2001; Griffin et al., 2002; Eckert et al., 2005). In the outer
layers of the skin and hair follicle, mainly keratinocyte-type
TG (TG1) and epidermal-type TG (TG3) are expressed.
Defective cross-linking of the cell envelope because of
mutations in the TGM1 gene has been found in patients
suffering from lammelar ichthyosis (Huber et al., 1995; Russel
et al., 1995). Accordingly, TGM1 knockout mice develop an
erythrodermic skin with impaired barrier function (Matsuki
et al., 1998). Although no in vivo role for TG3 has been
described, it is highly expressed in the late differentiating
keratinocytes, corneocytes, and the hair follicles. TG3 is also
a major antigen in dermatitis herpetiformis where TG3-IgA
immune complexes are deposited in the papillary dermis
(Sardy et al., 2002).
Recently, a transglutaminase 3 knockout (TGM3/KO) mouse
was generated that showed impaired hair development, but no
gross defects in the epidermal barrier (John et al., 2012). Here
we further investigated in these mice the functionality of the
skin barrier by a generally accepted and widely used Th2
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mouse model of contact hypersensitivity (CH) induced by the
hapten FITC solved in aceton and dibutyl-phtalate (DBP). We
found a significantly larger and more progressive cutaneous
inflammation at the site of FITC re-exposition in 24 and
48 hours in KO mice when compared with the C57BL/6
wild-type (WT) animals. In the current study, we used the
FITC–DBP system (Kripke et al., 1990; Sato et al., 1998; Imai
et al., 2006; Maruyama et al., 2007) with some modifications
and demonstrated, to our knowledge, a previously unreported
functional damage of the skin barrier in mice with genetic
absence of TG3.
RESULTS
TGM3/KO mice skin allows significantly stronger FITC
penetration in vivo by two-photon microscopy
We assessed the penetration pattern of FITC (solved in
dimethyl sulfoxide-distilled water) on the dorsal skin surface
of earlobes in anesthetized TGM3/KO and WT mice (n¼3 per
group) in vivo by two-photon microscopy. The penetration
pattern was different between KO and WT animals. In WT
mice, FITC showed a rather faint, scattered, and blurred
front of fluorescence during penetration through the
epidermis, in contrast to TGM3/KO mice in which a wide,
sharp, 20mm deep band-like fluorescence-front was detec-
table (Figure 1a and b) at 30 minutes. Quantification data
based on different representative orthogonal cuts of layers
captured at 30 minutes revealed significant 4.5±0.5-fold
increase of FITC fluorescence in TGM3/KO skin compared
with control WT skin.
By a two-photon imaging of the stained skin surface, the
stratum corneum presented distinctive fluorescence patterns
labeling more intensively the cornified cell envelope and
some corneocytes in KO than in WT animals, indicating
different penetration pattern through the barrier (Figure 1d).
TGM3 KO mice show significantly increased ear swelling in
response to FITC sensitization
First, we analyzed the increase in ear thickness (ET) in each
group 24 and 48 hours after FITC or vehicle re-exposure, and
analyzed the data for genders separately.
The average increase in ET (DET) among the FITC-treated
female TGM3/KO mice (n¼20) was 18±13mm at 24 hours,
and 61±19mm at 48 hours. In the group of WT female ani-
mals (n¼16), DET was 11±6mm at 24 hours and 16±12mm
at 48 hours, showing highly significant difference at 48 hours,
compared with KO animals (Po0.0001, Mann–Whitney test;
Figure 2a).
In the vehicle-treated female TGM3/KO group (n¼ 12), the
average extent of DET was 3±4mm at 24 hours and 17±14mm
at 48 hours, whereas in the vehicle-treated WT female group
(n¼9) this value was 6±3mm at 24 hours, and 7±9mm at
48 hours, respectively, showing no significant difference
(Figure 2b).
In the group of male mice, similar data were found.
The average DET in the group of FITC-treated male TGM/KO
mice (n¼ 18) was 19±16mm at 24 hours and 68±29mm at
48 hours. The FITC-treated WT male animals (n¼6) exhibited
an average DET of 10±7mm at 24 hours and 33±15mm at
48 hours, and these data were also significantly different
(Po0.0001, Mann–Whitney test) at the 48 hours evaluation.
Among the vehicle-treated male TGM3/KO mice (n¼ 14),
the average DET reached 2±3mm at 24 hours and 10±10mm
at 48 hours. Whereas in the vehicle-treated male WT group
(n¼ 5), these values were 3±4mm at 24 hours and 7±6mm at
48 hours, showing no significant difference between vehicle-
treated groups (data not shown).
Increased cutaneous inflammation in FITC sensitized TGM3/KO
mice
In parallel with the DET, the skin histology from the removed
ears in FITC-treated TGM3/KO and WT mice showed a
dermal infiltration of lymphocytes and neutrophils around
the dilated small arterioles and capillaries; however,
the inflammation was more pronounced /þþ / in TGM3/KO
than in WT /þ / animals by semiquantitative evaluation as
described in Materials and Methods. Both the TGM3/
KO /þþ / and WT /þ / FITC-treated animals developed
epidermal hyperproliferation and spongiosis. None of
the vehicle-treated animals displayed histological signs of
inflammation. (Figure 2c).
By toluidine blue staining, the number of subepidermal
mast cells did not differ in the FITC-treated TGM3/KO and WT
mice or in the vehicle-treated groups (data not shown). The
average mast cell number was 410 intensely stained mast
cells per field.
Demonstration of FITCþ cells in draining lymph nodes (LNs) and
increased level of activated T lymphocytes in FITC-sensitized
TGM3/KO animals
LN cell suspensions of FITC-treated KO and WT mice (n¼5
per group) were studied by flow cytometry. First, we wanted
to explore whether in FITC-challenged mice fluorescent
cells appear in the draining LNs. We could detect slightly
more FITCþ cells in TGM3/KO mice than in WT ones,
indicating that more FITCþ non-lymphocytic cells arrive
from the epidermis following FITC sensitization (data not
shown).
Next, we wondered whether draining LNs from TGM3/KO
animals developed increased lymphocyte activation after FITC
re-exposure. As shown in Figure 3, CD4þCD25þ cells
corresponding to the activated T-helper cells were highly
elevated in the TGM3/KO group compared with the WT
controls (Po0.01, Mann–Whitney test). In the case of the
vehicle treatment, there was no difference between the WT
and KO populations (data not shown).
Significantly elevated total serum IgE levels in FITC-treated
TGM3/KO mice
In parallel with T-cell activation, a significant growth in serum
IgE levels was measured in sera from FITC-treated TGM3/KO
mice compared with WT mice (n¼5 in each group).
The total serum IgE levels in FITC-treated WT mice was
868 ng ml 1±107 (SEM), whereas the total serum IgE in FITC-
treated TGM3/KO mice increased to 2,810 ng ml1±796
(SEM), the difference proved to be significant ((Po0.05)
P¼0.042, Student’s t–test; Figure 4).
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Figure 1. Penetration of FITC through stratum corneum in transglutaminase 3 knockout (TGM3/KO) and wild-type (WT) mice skin in vivo by two-photon
microscopy. (a, b) xz-Multitracking sections composed from a stack of xy-optical sections with 8mm distance were recorded from the skin surface (Z¼ 0mm) down
to the bottom. The representation reveals the frontal penetration profile of FITC in the TGM3/KO skin reaching an average of B20mm depth after 30 minutes.
A more limited FITC uptake was detected in WT skin both by line analysis (a) and by fluorescence imaging (b). The line analysis demonstrates the average
fluorescence intensity (on vertical axis) measured along 850mm length of the tissue sample (horizontal axis) (a). (c, d) Three-dimensional images also demonstrated
marked differences in FITC distribution pattern. Interconnected layers of coalescent FITC staining were found in TGM3/KO skin, whereas fine scattered FITC
fluorescence was found in the WT skin (d, c). 850mm length of the tissue sample is presented in panels a–c. On orthogonal cuts, a distinctive fluorescence pattern
labeled more intensively the cornified cell envelope and some corneocytes in KO than in WT animals and indicated different penetration through the barrier.
Quantification data showed significant 4.5±0.5-fold increase of FITC fluorescence in TGM3/KO mice compared with WT skin (bars¼ 200mm) (d) (study
performed altogether in three mice of each group; representative data are shown).
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Contrary, there was no significant difference in serum IgE
levels between FITC-naive TGM3/KO and WT mice (n¼ 5 in
each group; data not shown).
No difference in mouse ear swelling test (MEST) between
TGM3/KO and WT mice after intradermal Propionibacter
acnes injection
To investigate whether the immune system of the TGM3/KO
mice are generally more reactive to antigenes compared with
WT ones, we injected animals either with P. acnes suspension or
with phosphate-buffered saline (PBS) intradermally into their two
different earlobes (n¼3 per group). Under these circumstances,
independently of the epidermal barrier, the same amount of
antigen load met the immune system of KO and WT animals.
We evaluated the inflammation by MEST serving the contral-
ateral PBS-treated ear as control (Nakatsuji et al, 2009).
The average ET rate at 48 hours after P. acnes injection was
related to that after PBS injcetion and the difference was
27%±19.3% in TGM3/KO and 25%±12.2% in WT mice,
respectively (These values indicated no significant difference
between the two groups (P¼ 0.2254, Man–Whitney test;
Figure 5.). These data support the hypothesis that the higher
rate of CH to FITC in TGM3/KO mice is rather a consequence
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Figure 2. Significant ear thickening and histological signs of inflammation to FITC sensitization in transglutaminase 3 knockout (TGM3/KO) compared with
wild-type (WT) mice. On the vertical axis, ear thickening is indicated in mm. ‘‘&’’ TGM3/KO, ‘‘D’’ WT mice. A significant ear thickening was detectable upon
FITC treatment, between KO and WT animals at 48 hours (a). Although the difference was not significant, there was also more thickening in the vehicle-treated KO
mice than in the vehicle WT mice (b). (c) Histology is shown for the filled symbols. TGM3/KO mice at 48 hours showed with prominent inflammation, dermal
infiltration, epidermal thickening, spongiosis, and notable crust formation (marked with ‘‘*’’). WT mice developed mild-to-moderate inflammatory cell infiltration
and thickened epidermis upon FITC sensitization. Vehicle-treated WT and TGM3/KO mice showed only mild edema. ***Pp0,0001, Mann–Whitney test.
Bar¼40mm.
30
TGM3 KO
104
104
103
103
102
102
CD
4
CD25
101
101
100
100
WT**
25
20
15
10
%
 L
ym
ph
oc
yt
e 
ga
te
5
0
CD4+ CD25 + CD4+ CD25 +
Figure 3. FACS analysis of draining lymph nodes shows an increased
population of activated T-helper cells upon FITC treatment in
transglutaminase 3 knockout (TGM3/KO) mice. Cells were isolated from
draining lymph nodes 48 hours after re-exposure to FITC. In the inset (upper
right corner), distribution of lymph node cells are shown in a FITC-treated
TGM3/KO mice. Empty bars refer to TGM3/KO, black bars for wild-type (WT)
mice. Data are mean±SEM (n¼ 5). Activated T-helper cells were highly
elevated in the FITC-treated TGM3/KO group when compared with the
FITC-treated WT controls (**Po0.01, Mann–Whitney test).
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Figure 4. Significantly elevated total serum IgE levels in FITC-treated
transglutaminase 3 knockout (TGM3/KO) mice. Significantly higher serum
IgE levels in sera from FITC-treated TGM3/KO mice when compared with
wild-type (WT) mice. Total serum IgE level in FITC-treated WT mice was
868 ng ml 1±107 (SEM), whereas the total serum IgE in FITC-treated
TGM3/KO mice increased to 2,810 ng ml 1±796 (SEM). Empty bars refer
to TGM3/KO, black bars to WT female mice. Data are mean±SEM (n¼ 5;
*Po0.05, Student’s t-test).
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Figure 5. Propionibacter acnes induced mouse ear swelling test response 1014
colony-forming unit of P. acnes were injected intradermally to earlobes of
transglutaminase 3 knockout (TGM3/KO) and wild-type (WT) mice. DEar
thickness (ET) was evaluated at 24 hours. On the vertical axis, DET is shown in
percentage (data are mean±SEM, n¼3), empty column refers to TGM3/KO,
black to WT mice. Ear swelling response to P. acnes antigen load does not
show significant difference between the two groups.
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of an impaired skin barrier than an increased activity of the
TGM3/KO immune system.
DISCUSSION
Defects of structural proteins like filaggrin (Sandilands et al.,
2007; Giwercman et al., 2008), or protease inhibitors (serine
protease inhibitor Kazal-type 5) and cross-linking enzymes
such as TG1, have been shown to be associated with
damaged cornified cell envelope formation and an
enhanced percutaneous sensitization rate (reviewed by
Kubo et al., 2012). The role of TG3, a transglutaminase
present in the cornified cell envelop and the uppermost layer
of the stratum granulosum, however, remains largely
unexplored in these processes. Unexpectedly, the recently
developed TGM3/KO mice did not show any major barrier
defect under steady-state conditions as indicated by the
normal transepidermal water loss, dye penetration, and
intact skin structure, although an increased fragility of the
isolated corneocytes was detected (John et al., 2012).
To further analyze the function and pathology of the
apparently normal cutaneous barrier in animals without
TG3, we chose to study the development of CH in a well-
characterized FITC-induced CH mouse model. Using MEST,
we detected a more severe inflammatory response in the KO
animals as compared with the control group, peaking at
48 hours. Vehicle (aceton/DBP)-treated control mice showed
only mild edema without significant inflammatory infiltration.
KO mice showed somewhat more reaction than WT animals,
but without reaching significance (Figure 2).
Although the detailed immunological analysis of FITC-
induced CH generally was beyond the scope of this paper,
we evaluated the CD4/CD25-activated T-cell population
collected from the draining LNs, and TGM3/KO mice had
significantly more activated T cells than WT cells upon FITC
re-exposure, a further indicator of CH. Considering that
immune responses on the background of TGM3/KO mice
(C57BL/6 strain) are predominantly Th-1-biased (Takeshita
et al., 2004), the observed significant increase in serum IgE
levels in FITC-sensitized TGM3/KO animals suggested a
percutaneously induced Th2-dominated adaptive immune
response (Dearman and Kimber, 2000, Larson et al., 2010).
To test the non-percutaneously induced immune reactivity
of TGM3/KO mice, we injected P. acnes intradermally to the
ears of untreated mice. These bacteria are known to evoke a
strong, long-lasting immune response in loco (Nakatsuji et al.,
2009). The similar reactivity of KO and WT animals to
P. acnes indicated that the more severe CH provoked by
FITC in TGM3/KO mice is due to an impaired skin barrier
rather than a generally increased reactivity of the cutaneous
immune system for other reasons.
Contrary to the normal fluorescent dye penetration observed
by John et al. (2012), in this study we experienced an
enhanced FITC entry through the cornified envelope. The
different outcome can be due to the stereochemically different
dyes used; Lucifer yellow has a larger molecular mass, and a
vastly different water/lipid solubility as opposed to FITC, the
dye that we studied. Furthermore, the penetration studies were
performed previously on cadaver back skin of newborn mice,
whereas in our experiments we studied 8- to 12-week-old
animals and focused on the ear. It is well -known that there
are structural and physiological differences between the two
skin areas. Also, two-photon microscopy is considered to be a
much more sensitive and precise technique than plain
fluorescence microscopy, which enables us to follow real-
time dye penetration.
The different FITC penetration patterns in KO and WT
animals and a 4.5±0.5-fold FITC fluorescence increment in
TGM3/KO compared with WT skin detected by in vivo two-
photon microscopy may serve as a further proof of damaged
skin barrier function in TGM3/KO animals. The normal
transepidermal water loss in these animals do not contradict
our results, as the filaggrin-deficient flacky-tail mice also
showed almost normal transepidermal water loss but exhibited
a paracellular barrier defect and a reduced inflammatory
threshold to haptens and irritants (Scharschmidt et al., 2009).
All these studies verified a clinically latent barrier defect in
TGM3/KO mice, which is associated with a significant
susceptibility to sensitization upon percutaneous FITC chal-
lenge and indicates a reduced inflammatory threshold.
Consequently, these data suggest that the enzymatic activity
of TG3 has a remarkable contribution to the epidermal barrier
function.
MATERIALS AND METHODS
Mice
TGM3/KO mice (John et al, 2012) on a C57/BL6 backround (males
n¼ 32, females n¼ 32) and WT animals (females n¼ 25, males
n¼ 11) were studied for CH (8- to 12-week old). Further 6-6 mice
were used for two-photon microscopy and P. acnes studies. Animals
were provided food and water without restrictions, and were placed
separately in cages for 24 hours before the experiment. The
experiments were approved by the local ethical committee.
Contact sensitization and MEST
In all mice, the abdomen was shaved on testday (day) 0 (one day before
the epicutanoeous patch installation). On day 1, an occlusive patch
(Finn Chamber, diameter 18 mm (Phoenix, AZ)) saturated with 160ml of
0.5% FITC solved in acetone/ DBP (all reagents were purchased from
Sigma-Aldrich, St Louis, MO) 1:1 (v/v) mixture was fixed with adhesive
tape to the prepared skin for 24hours in knockout and WT mice.
Control groups of KO and WT mice were exposed to solvent (acetone/
DBP) only. The patches were removed after 24 hours (on day 2).
On day 7, the same area of the abdomen was shaved again, and on
day 8, the mice were again exposed here to FITC, or to the solvent
under occlusive patches.
On day 15, the baseline ET (0 hour) was measured with a digital
thickness gauge just below the apex of the ear. Then the mice were
challenged by 20ml of FITC solution (0.5% FITC in acetone/DBP) on
the back of both ears of the FITC-exposed animal. The control group
was challenged with 20ml of acetone/DBT. Thickening of both ears
was measured at 24 and 48 hours.
Histology
Immediately after the 48 hours ET evaluation, the mice were eutha-
nized with sodium thiopenthal (Sandoz Pharmaceutical Company,
Budapest, Hungary), and both earlobes were removed.
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The earlobe samples were fixed in 10% neutrally buffered
formalin, and were subjected to a standard protocol of dehydration,
paraffin embedding, sectioning, and staining with hematoxylin and
eosin. The histological evaluation was performed blinded. We used
the methods described by Hvid et al. (2009) with modifications. To
assess the grade of inflammation, we scored the epidermal
hyperplasia, spongiosis, and the presence of inflammatory cell infil-
tration in the dermis. A grading scale from ‘‘0’’ (no histopathological
findings of inflammation) to ‘‘þþ ’’ (severe inflammatory reaction)
was used through the study.
The average number of mast cells with strong toluidine blue
staining in the subepidermal area was also determined in five
randomly selected microscopic fields at  200 magnification. The
used ‘‘mast cell grading scale’’ was as follows: ‘‘0’’¼ 0–5 mast cells
per field, ‘‘þ ’’: 6–10 mast cells per field, and ‘‘þþ ’’410 intensely
stained mast cells per field.
Flow cytometry
Forty-eight hours after the FITC challenge on the earlobes, the
draining brachial LNs (LN; 2–4 LNs per animal) were removed and
single-cell suspension was prepared by gentle teasing with needles.
Cells were stained with phycoerythrin-conjugated anti-mouse CD3,
Peridinin Chlorophyll Protein Complex-conjugated anti-mouse CD4,
and phycoerythrin-conjugated anti-mouse CD25 antibodies (all from
BD Biosciences, San Jose, CA, USA). Measurments were also
performed on unlabeled LN cells in order to detect the fluorescence
at the wavelength of FITC in the non-lymphoid gate. The cells were
studied by a Becton Dickinson FACSCalibur flow cytometer (Becton
Dickinson, San Jose, CA), and the results were evaluated by the
CellQuest programme version 3.1 (San Jose, CA).
Serum IgE ELISA
At the 48 hours ET evaluation, sera were obtained from both
FITC-treated TGM3/KO and WT mice, and kept frozen at  20 C1
until ELISA measurements.
Total serum IgE levels were measured with a commercially
available mouse IgE ELISA KIT (BD Biosciences, Mouse IgE ELISA
set, cat. no. 555248) together with the additional reagent set (BD
Biosciences, OptEIA Reagent Set B (pH9.5 buffer) cat. no 550534)
according to instructions provided by the manufacturer.
In vivo two-photon microscopy to analyze cutaneous FITC
penetration in TGM3/KO and WT mice
Mice (n¼ 3 per group) were anesthetized and their earlobes were
attached to microscopic slides with Vetbond 3M (3M, St Paul, MN)
tissue adhesive.
FITC stock solution (5 mg ml 1 in dimethyl sulfoxide) was diluted
1:100 in nanopure water. A 2ml drop was deposited onto the dorsal
skin surface of the ear and was allowed to dry. Penetration of the
fluorophore was measured by in vivo two-photon absorption fluor-
escence microscopy (Denk et al, 1990) and evaluated after 15, 30,
and 40 minutes by a Carl Zeiss LSM 7 MP laser scanning microscope
(Carl Zeiss, Jena, Germany). An optically pumped mode-locked
Ti:sapphire laser (FemtoRose 100 TUN NoTouch, R&D Ultrafast
Lasers, Budapest, Hungary) was used as a two-photon excitation
source at a center wavelength of B795 nm. The laser delivered
B190 fs pulses at a repetiton rate of B76 MHz and had a Gaussian
beam profile. The FITC fluorophore could be effectively excited at this
wavelength (Periasamy, 2001). The average power was set by an
acousto-optic device with a slight chromatic dispersion (DlFWHM
B40 nm), not affecting the optical pulse focusability in a spectral
bandwidth of DlFWHMB5 nm. The average laser power was set to
B20 mW, providing a high-fluorescence signal but no thermal or
genetic damage to the sample (Antal and Szip+ocs, 2012). Laser beam
was focused by a  20 water immersion objective, which also
collected the fluorescent signal from the sample to a non-descanned
detector. The signal passed a long pass (l4680 nm) dichroic filter, a
corresponding laser-blocking filter, and a 500–550 nm bandpass filter
before reaching the non-descanned detector.
Tissue samples (850 850 80mm3) from anesthetized KO and
WT animals were optically sliced starting from the outer surface of
stratum corneum in 8mm increments (z-stack measurements). The
Three-dimensional images were captured and analyzed by the
commercial ZEN software (Carl Zeiss) of the two-photon microscope.
Quantification of fluorescein imaging was performed at 30minutes
based on three independent experiments using three representative
orthogonal cuts of 11 layers at 8mm distance from each other, and were
visualized as line analysis individually measured. For fluorescence
intensity analysis, publicly free access UTHSCA Image Tool for Windows
version 3.00 was used. Integrated fluorescence density was calculated on
the full area of orthogonal cuts (Breunig et al, 2012, Ko¨nig, 2000)
P. acnes induced ear swelling
TGM3/KO and WT mice (n¼ 3 per group) were injected with 20ml of
P. acnes suspended in sterile PBS (1 1014 colony-forming unit) into
the dorsal proximal site of left earlobe. As a negative control, the right
earlobe was similarly treated with 20ml PBS.
After 48 hours, the ear swelling response was measured with a
digital thickness gauge.
The rate of left ear swelling to P. acnes was related to the PBS-
induced ET and was given in percentage.
Statistical analysis
Data were analyzed by IBM SPSS Statistics 19 Software (IBM,
Armonk, NY) using standard non-parametric Mann–Whitney test or
Student’s t-test.
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